Business Context and Reporting Period
Pavmed Inc. filed this Form 8-K on April 16, 2018, reporting events that occurred on April 13, 2018. The company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
The primary material change reported is the elimination of specific classes of preferred stock:
- On April 13, 2018, the Company filed a Certificate of Elimination with the Delaware Secretary of State.
- This action removed the Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock from the Company's Certificate of Incorporation.
- As of the filing date, there are no outstanding shares of Series A or Series A-1 Convertible Preferred Stock.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure that the description of the Certificate of Elimination is subject to the full text of the attached exhibit.
Investor Verification Checklist
- Confirm the full text of the Certificate of Elimination (Exhibit 3.1) to understand any residual rights or conditions.
- Verify the current capital structure to ensure no other preferred stock series remain outstanding.
- Review subsequent filings for any impact of this elimination on the company's financial reporting or equity dilution.